Key differences
Jump to the supporting row.
Comparison
Dermatology
Pathology
Training & seats
NMC broad-specialty seatsOfficial data
NBEMS DNB post-MBBS seatsOfficial data
NBEMS post-diploma seatsOfficial data
Demand & work
Healthcare / service needEvidence summary
Skin disease creates broad outpatient demand across inflammatory, infectious, pigmentary and procedural care.Supporting evidence ↗
Cancer diagnosis, histopathology, hematology and laboratory medicine create demand across hospitals and diagnostic networks.Supporting evidence ↗
Typical work settingsEditorial synthesis
Outpatient practice, hospitals, academic departments, procedures and aesthetic/dermatologic services.
Hospital laboratories, diagnostic chains, academic centers, molecular labs and industry.
Practice economics
Capital to enter independent practiceEditorial synthesis
Low to moderate for medical dermatology; higher for procedure-heavy or aesthetic practice.
Low for employed/academic practice; substantial for independent laboratory ownership depending on scope.
After MD / MS / DNB
NEET-SS courses this degree qualifies you for2026 eligibilityCourses can be shared across feeder specialties. The number is an eligibility count, not a count of courses exclusive to that specialty. NEET-SS only; INI-SS pathways are separate. Duplicate course entries in the bulletin are counted once.
0No NEET-SS course is listed for this broad specialty beyond the separate Medical Genetics broad-specialty route.NEET-SS 2026 bulletin · Annexure A, pp. 132–135 ↗
NEET-SS route open to broad specialties2026 eligibility
Medical Genetics is available through the bulletin’s broad-specialty eligibility route.NEET-SS 2026 bulletin · Annexure A ↗
Medical Genetics is available through the same broad-specialty eligibility route.NEET-SS 2026 bulletin · Annexure A ↗
Other further trainingEditorial synthesis
Dermatosurgery, dermatopathology, pediatric dermatology, trichology, immunodermatology and procedural/aesthetic fellowships. Recognition and entry criteria vary.
Focused training in molecular pathology, hematopathology, neuropathology, renal pathology, cytopathology and laboratory management. Recognition varies.
Technology & industry
AI & technology exposureEditorial synthesis
Image classification and triage are advancing, but dataset bias and real-world validation remain important.
Digital pathology, whole-slide imaging, triage and AI-assisted image analysis.
Research & industry pathwaysEditorial synthesis
Dermatology pharma, biologics, devices, aesthetics and clinical research.
Diagnostics, molecular testing, pharma biomarkers, trials and laboratory technology.
NMC and NBEMS figures are regulatory snapshots and may be revised. NEET-SS eligibility reflects the 2026 Information Bulletin; counts show courses a feeder degree qualifies for, including courses shared with other feeder specialties. INI-SS pathways are outside these counts. Reviewed 1 Nov 2026. How we source data.